世界のダニ媒介性脳炎ワクチン市場予測 2021年-2026年

【英語タイトル】Global Tick-borne Encephalitis Vaccine Market Growth 2021-2026

LP Informationが出版した調査資料(LPI21MY9672)・商品コード:LPI21MY9672
・発行会社(調査会社):LP Information
・発行日:2021年5月(※2024年版があります。お問い合わせください)
・ページ数:137
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,660 ⇒換算¥541,680見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,490 ⇒換算¥812,520見積依頼/購入/質問フォーム
Corporate User(閲覧人数制限なし)USD7,320 ⇒換算¥1,083,360見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
LPインフォメーション社の「ダニ媒介性脳炎ワクチンの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ヨーロッパTBEウイルス、極東TBEウイルス、シベリアTBEウイルスなど、用途別には、小児用ワクチン、成人用ワクチン、旅行者用ワクチンなどにセグメント区分してまとめました。ダニ媒介性脳炎ワクチンのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・ダニ媒介性脳炎ワクチンの世界市場概要(サマリー)
・ダニ媒介性脳炎ワクチンの企業別販売量・売上
・ダニ媒介性脳炎ワクチンの企業別市場シェア
・ダニ媒介性脳炎ワクチンの世界市場規模 2016年-2021年:種類別(ヨーロッパTBEウイルス、極東TBEウイルス、シベリアTBEウイルス)
・ダニ媒介性脳炎ワクチンの世界市場規模 2016年-2021年:用途別(小児用ワクチン、成人用ワクチン、旅行者用ワクチン)
・ダニ媒介性脳炎ワクチンの南北アメリカ市場規模(アメリカ、カナダ、メキシコなど)
・ダニ媒介性脳炎ワクチンのアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・ダニ媒介性脳炎ワクチンのヨーロッパ市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・ダニ媒介性脳炎ワクチンの中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・ダニ媒介性脳炎ワクチン市場の成長要因・課題・動向
・ダニ媒介性脳炎ワクチンの世界市場予測 2021年-2026年
・ダニ媒介性脳炎ワクチンの南北アメリカ市場予測(アメリカ、カナダ、メキシコなど)
・ダニ媒介性脳炎ワクチンのアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・ダニ媒介性脳炎ワクチンのヨーロッパ市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・ダニ媒介性脳炎ワクチンの中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・ダニ媒介性脳炎ワクチンの世界市場予測:種類別(ヨーロッパTBEウイルス、極東TBEウイルス、シベリアTBEウイルス)
・ダニ媒介性脳炎ワクチンの世界市場予測:用途別(小児用ワクチン、成人用ワクチン、旅行者用ワクチン)
・主要企業分析
【レポートの概要】

According to this latest study, the 2020 growth of Tick-borne Encephalitis Vaccine will have significant change from previous year. By the most conservative estimates of global Tick-borne Encephalitis Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Tick-borne Encephalitis Vaccine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Tick-borne Encephalitis Vaccine market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
European TBE Virus
Far Eastern TBE Virus
Siberian TBE Virus

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Pediatric Vaccines
Adult Vaccines
Traveler Vaccines

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
Pfizer
Encephalitis
Cochrane Collaboration
Sonic HealthPlus
Superdrug Health

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Tick-borne Encephalitis Vaccine Consumption 2016-2026
2.1.2 Tick-borne Encephalitis Vaccine Consumption CAGR by Region
2.2 Tick-borne Encephalitis Vaccine Segment by Type
2.2.1 European TBE Virus
2.2.2 Far Eastern TBE Virus
2.2.3 Siberian TBE Virus
2.3 Tick-borne Encephalitis Vaccine Sales by Type
2.3.1 Global Tick-borne Encephalitis Vaccine Sales Market Share by Type (2016-2021)
2.3.2 Global Tick-borne Encephalitis Vaccine Revenue and Market Share by Type (2016-2021)
2.3.3 Global Tick-borne Encephalitis Vaccine Sale Price by Type (2016-2021)
2.4 Tick-borne Encephalitis Vaccine Segment by Application
2.4.1 Pediatric Vaccines
2.4.2 Adult Vaccines
2.4.3 Traveler Vaccines
2.5 Tick-borne Encephalitis Vaccine Sales by Application
2.5.1 Global Tick-borne Encephalitis Vaccine Sale Market Share by Application (2016-2021)
2.5.2 Global Tick-borne Encephalitis Vaccine Revenue and Market Share by Application (2016-2021)
2.5.3 Global Tick-borne Encephalitis Vaccine Sale Price by Application (2016-2021)

3 Global Tick-borne Encephalitis Vaccine by Company
3.1 Global Tick-borne Encephalitis Vaccine Sales Market Share by Company
3.1.1 Global Tick-borne Encephalitis Vaccine Sales by Company (2019-2021)
3.1.2 Global Tick-borne Encephalitis Vaccine Sales Market Share by Company (2019-2021)
3.2 Global Tick-borne Encephalitis Vaccine Revenue Market Share by Company
3.2.1 Global Tick-borne Encephalitis Vaccine Revenue by Company (2019-2021)
3.2.2 Global Tick-borne Encephalitis Vaccine Revenue Market Share by Company (2019-2021)
3.3 Global Tick-borne Encephalitis Vaccine Sale Price by Company
3.4 Global Manufacturers Tick-borne Encephalitis Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Tick-borne Encephalitis Vaccine Product Location Distribution
3.4.2 Players Tick-borne Encephalitis Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Tick-borne Encephalitis Vaccine by Region
4.1 Global Tick-borne Encephalitis Vaccine by Region
4.1.1 Global Tick-borne Encephalitis Vaccine Sales by Region
4.1.2 Global Tick-borne Encephalitis Vaccine Revenue by Region
4.2 Americas Tick-borne Encephalitis Vaccine Sales Growth
4.3 APAC Tick-borne Encephalitis Vaccine Sales Growth
4.4 Europe Tick-borne Encephalitis Vaccine Sales Growth
4.5 Middle East & Africa Tick-borne Encephalitis Vaccine Sales Growth

5 Americas
5.1 Americas Tick-borne Encephalitis Vaccine Sales by Country
5.1.1 Americas Tick-borne Encephalitis Vaccine Sales by Country (2016-2021)
5.1.2 Americas Tick-borne Encephalitis Vaccine Revenue by Country (2016-2021)
5.2 Americas Tick-borne Encephalitis Vaccine Sales by Type
5.3 Americas Tick-borne Encephalitis Vaccine Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Tick-borne Encephalitis Vaccine Sales by Region
6.1.1 APAC Tick-borne Encephalitis Vaccine Sales by Region (2016-2021)
6.1.2 APAC Tick-borne Encephalitis Vaccine Revenue by Region (2016-2021)
6.2 APAC Tick-borne Encephalitis Vaccine Sales by Type
6.3 APAC Tick-borne Encephalitis Vaccine Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Tick-borne Encephalitis Vaccine by Country
7.1.1 Europe Tick-borne Encephalitis Vaccine Sales by Country (2016-2021)
7.1.2 Europe Tick-borne Encephalitis Vaccine Revenue by Country (2016-2021)
7.2 Europe Tick-borne Encephalitis Vaccine Sales by Type
7.3 Europe Tick-borne Encephalitis Vaccine Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Tick-borne Encephalitis Vaccine by Country
8.1.1 Middle East & Africa Tick-borne Encephalitis Vaccine Sales by Country (2016-2021)
8.1.2 Middle East & Africa Tick-borne Encephalitis Vaccine Revenue by Country (2016-2021)
8.2 Middle East & Africa Tick-borne Encephalitis Vaccine Sales by Type
8.3 Middle East & Africa Tick-borne Encephalitis Vaccine Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Tick-borne Encephalitis Vaccine Distributors
10.3 Tick-borne Encephalitis Vaccine Customer

11 Global Tick-borne Encephalitis Vaccine Market Forecast
11.1 Global Tick-borne Encephalitis Vaccine Forecast by Region
11.1.1 Global Tick-borne Encephalitis Vaccine Forecast by Regions (2021-2026)
11.2.2 Global Tick-borne Encephalitis Vaccine Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Countries
11.3 APAC Forecast by Region
11.4 Europe Forecast by Countries
11.5 Middle East & Africa Forecast by Countries
11.6 Global Tick-borne Encephalitis Vaccine Forecast by Type
11.7 Global Tick-borne Encephalitis Vaccine Forecast by Application

12 Key Players Analysis
12.1 Pfizer
12.1.1 Pfizer Pfizer Company Information
12.1.2 Pfizer Tick-borne Encephalitis Vaccine Product Offered
12.1.3 Pfizer Tick-borne Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Pfizer Main Business Overview
12.1.5 Pfizer Latest Developments
12.2 Encephalitis
12.2.1 Encephalitis Company Information
12.2.2 Encephalitis Tick-borne Encephalitis Vaccine Product Offered
12.2.3 Encephalitis Tick-borne Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Encephalitis Main Business Overview
12.2.5 Encephalitis Latest Developments
12.3 Cochrane Collaboration
12.3.1 Cochrane Collaboration Company Information
12.3.2 Cochrane Collaboration Tick-borne Encephalitis Vaccine Product Offered
12.3.3 Cochrane Collaboration Tick-borne Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Cochrane Collaboration Main Business Overview
12.3.5 Cochrane Collaboration Latest Developments
12.4 Sonic HealthPlus
12.4.1 Sonic HealthPlus Company Information
12.4.2 Sonic HealthPlus Tick-borne Encephalitis Vaccine Product Offered
12.4.3 Sonic HealthPlus Tick-borne Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Sonic HealthPlus Main Business Overview
12.4.5 Sonic HealthPlus Latest Developments
12.5 Superdrug Health
12.5.1 Superdrug Health Company Information
12.5.2 Superdrug Health Tick-borne Encephalitis Vaccine Product Offered
12.5.3 Superdrug Health Tick-borne Encephalitis Vaccine Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Superdrug Health Main Business Overview
12.5.5 Superdrug Health Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Tick-borne Encephalitis Vaccine Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of European TBE Virus
Table 3. Major Players of Far Eastern TBE Virus
Table 4. Major Players of Siberian TBE Virus
Table 5. Global Tick-borne Encephalitis Vaccine Sales by Type (2016-2021) & (K Doses)
Table 6. Global Tick-borne Encephalitis Vaccine Sales Market Share by Type (2016-2021)
Table 7. Global Tick-borne Encephalitis Vaccine Revenue by Type (2016-2021) & ($ million)
Table 8. Global Tick-borne Encephalitis Vaccine Revenue Market Share by Type (2016-2021)
Table 9. Global Tick-borne Encephalitis Vaccine Sale Price by Type (2016-2021)
Table 10. Global Tick-borne Encephalitis Vaccine Sales by Application (2016-2021) & (K Doses)
Table 11. Global Tick-borne Encephalitis Vaccine Sales Market Share by Application (2016-2021)
Table 12. Global Tick-borne Encephalitis Vaccine Value by Application (2016-2021)
Table 13. Global Tick-borne Encephalitis Vaccine Revenue Market Share by Application (2016-2021)
Table 14. Global Tick-borne Encephalitis Vaccine Sale Price by Application (2016-2021)
Table 15. Global Tick-borne Encephalitis Vaccine Sales by Company (2019-2021) & (K Doses)
Table 16. Global Tick-borne Encephalitis Vaccine Sales Market Share by Company (2019-2021)
Table 17. Global Tick-borne Encephalitis Vaccine Revenue by Company (2019-2021) ($ Millions)
Table 18. Global Tick-borne Encephalitis Vaccine Revenue Market Share by Company (2019-2021)
Table 19. Global Tick-borne Encephalitis Vaccine Sale Price by Company (2019-2021)
Table 20. Key Manufacturers Tick-borne Encephalitis Vaccine Producing Area Distribution and Sales Area
Table 21. Players Tick-borne Encephalitis Vaccine Products Offered
Table 22. Tick-borne Encephalitis Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Tick-borne Encephalitis Vaccine Sales by Region (2016-2021) (K Doses)
Table 26. Global Tick-borne Encephalitis Vaccine Sales Market Share by Region (2016-2021)
Table 27. Global Tick-borne Encephalitis Vaccine Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global Tick-borne Encephalitis Vaccine Revenue Market Share by Region (2016-2021)
Table 29. Americas Tick-borne Encephalitis Vaccine Sales by Country (2016-2021) & (K Doses)
Table 30. Americas Tick-borne Encephalitis Vaccine Sales Market Share by Country (2016-2021)
Table 31. Americas Tick-borne Encephalitis Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas Tick-borne Encephalitis Vaccine Revenue Market Share by Country (2016-2021)
Table 33. Americas Tick-borne Encephalitis Vaccine Sales by Type (2016-2021) & (K Doses)
Table 34. Americas Tick-borne Encephalitis Vaccine Sales Market Share by Type (2016-2021)
Table 35. Americas Tick-borne Encephalitis Vaccine Sales by Application (2016-2021) & (K Doses)
Table 36. Americas Tick-borne Encephalitis Vaccine Sales Market Share by Application (2016-2021)
Table 37. APAC Tick-borne Encephalitis Vaccine Sales by Region (2016-2021) & (K Doses)
Table 38. APAC Tick-borne Encephalitis Vaccine Sales Market Share by Region (2016-2021)
Table 39. APAC Tick-borne Encephalitis Vaccine Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC Tick-borne Encephalitis Vaccine Revenue Market Share by Region (2016-2021)
Table 41. APAC Tick-borne Encephalitis Vaccine Sales by Type (2016-2021) & (K Doses)
Table 42. APAC Tick-borne Encephalitis Vaccine Sales Market Share by Type (2016-2021)
Table 43. APAC Tick-borne Encephalitis Vaccine Sales by Application (2016-2021) & (K Doses)
Table 44. APAC Tick-borne Encephalitis Vaccine Sales Market Share by Application (2016-2021)
Table 45. Europe Tick-borne Encephalitis Vaccine Sales by Country (2016-2021) & (K Doses)
Table 46. Europe Tick-borne Encephalitis Vaccine Sales Market Share by Country (2016-2021)
Table 47. Europe Tick-borne Encephalitis Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe Tick-borne Encephalitis Vaccine Revenue Market Share by Country (2016-2021)
Table 49. Europe Tick-borne Encephalitis Vaccine Sales by Type (2016-2021) & (K Doses)
Table 50. Europe Tick-borne Encephalitis Vaccine Sales Market Share by Type (2016-2021)
Table 51. Europe Tick-borne Encephalitis Vaccine Sales by Application (2016-2021) & (K Doses)
Table 52. Europe Tick-borne Encephalitis Vaccine Sales Market Share by Application (2016-2021)
Table 53. Middle East & Africa Tick-borne Encephalitis Vaccine Sales by Country (2016-2021) & (K Doses)
Table 54. Middle East & Africa Tick-borne Encephalitis Vaccine Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa Tick-borne Encephalitis Vaccine Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa Tick-borne Encephalitis Vaccine Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa Tick-borne Encephalitis Vaccine Sales by Type (2016-2021) & (K Doses)
Table 58. Middle East & Africa Tick-borne Encephalitis Vaccine Sales Market Share by Type (2016-2021)
Table 59. Middle East & Africa Tick-borne Encephalitis Vaccine Sales by Application (2016-2021) & (K Doses)
Table 60. Middle East & Africa Tick-borne Encephalitis Vaccine Sales Market Share by Application (2016-2021)
Table 61. Global Tick-borne Encephalitis Vaccine Sales Forecast by Type (2021-2026) & (K Doses)
Table 62. Global Tick-borne Encephalitis Vaccine Sales Market Share Forecast by Type (2021-2026)
Table 63. Global Tick-borne Encephalitis Vaccine Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 64. Global Tick-borne Encephalitis Vaccine Revenue Market Share Forecast by Type (2021-2026)
Table 65. Global Tick-borne Encephalitis Vaccine Sales Forecast by Application (2021-2026) & (K Doses)
Table 66. Global Tick-borne Encephalitis Vaccine Sales Market Share Forecast by Application (2021-2026)
Table 67. Global Tick-borne Encephalitis Vaccine Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 68. Global Tick-borne Encephalitis Vaccine Revenue Market Share Forecast by Application (2021-2026)
Table 69. Pfizer Basic Information, Tick-borne Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 70. Pfizer Tick-borne Encephalitis Vaccine Product Offered
Table 71. Pfizer Tick-borne Encephalitis Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 72. Pfizer Main Business
Table 73. Pfizer Latest Developments
Table 74. Encephalitis Basic Information, Tick-borne Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 75. Encephalitis Tick-borne Encephalitis Vaccine Product Offered
Table 76. Encephalitis Tick-borne Encephalitis Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 77. Encephalitis Main Business
Table 78. Encephalitis Latest Developments
Table 79. Cochrane Collaboration Basic Information, Tick-borne Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 80. Cochrane Collaboration Tick-borne Encephalitis Vaccine Product Offered
Table 81. Cochrane Collaboration Tick-borne Encephalitis Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 82. Cochrane Collaboration Main Business
Table 83. Cochrane Collaboration Latest Developments
Table 84. Sonic HealthPlus Basic Information, Tick-borne Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 85. Sonic HealthPlus Tick-borne Encephalitis Vaccine Product Offered
Table 86. Sonic HealthPlus Tick-borne Encephalitis Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 87. Sonic HealthPlus Main Business
Table 88. Sonic HealthPlus Latest Developments
Table 89. Superdrug Health Basic Information, Tick-borne Encephalitis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 90. Superdrug Health Tick-borne Encephalitis Vaccine Product Offered
Table 91. Superdrug Health Tick-borne Encephalitis Vaccine Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)
Table 92. Superdrug Health Main Business
Table 93. Superdrug Health Latest Developments
List of Figures
Figure 1. Picture of Tick-borne Encephalitis Vaccine
Figure 2. Tick-borne Encephalitis Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Tick-borne Encephalitis Vaccine Sales Growth Rate 2016-2026 (K Doses)
Figure 7. Global Tick-borne Encephalitis Vaccine Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Tick-borne Encephalitis Vaccine Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of European TBE Virus
Figure 10. Product Picture of Far Eastern TBE Virus
Figure 11. Product Picture of Siberian TBE Virus
Figure 12. Global Tick-borne Encephalitis Vaccine Sales Market Share by Type in 2020
Figure 13. Global Tick-borne Encephalitis Vaccine Revenue Market Share by Type (2016-2021)
Figure 14. Tick-borne Encephalitis Vaccine Consumed in Pediatric Vaccines
Figure 15. Global Tick-borne Encephalitis Vaccine Market: Pediatric Vaccines (2016-2021) & (K Doses)
Figure 16. Tick-borne Encephalitis Vaccine Consumed in Adult Vaccines
Figure 17. Global Tick-borne Encephalitis Vaccine Market: Adult Vaccines (2016-2021) & (K Doses)
Figure 18. Tick-borne Encephalitis Vaccine Consumed in Traveler Vaccines
Figure 19. Global Tick-borne Encephalitis Vaccine Market: Traveler Vaccines (2016-2021) & (K Doses)
Figure 20. Global Tick-borne Encephalitis Vaccine Sales Market Share by Application (2016-2021)
Figure 21. Global Tick-borne Encephalitis Vaccine Revenue Market Share by Application in 2020
Figure 22. Global Tick-borne Encephalitis Vaccine Revenue Market by Company in 2020 ($ Million)
Figure 23. Global Tick-borne Encephalitis Vaccine Revenue Market Share by Company in 2020
Figure 24. Global Tick-borne Encephalitis Vaccine Sales Market Share by Regions (2016-2021)
Figure 25. Global Tick-borne Encephalitis Vaccine Revenue Market Share by Region in 2020
Figure 26. Americas Tick-borne Encephalitis Vaccine Sales 2016-2021 (K Doses)
Figure 27. Americas Tick-borne Encephalitis Vaccine Revenue 2016-2021 ($ Millions)
Figure 28. APAC Tick-borne Encephalitis Vaccine Sales 2016-2021 (K Doses)
Figure 29. APAC Tick-borne Encephalitis Vaccine Revenue 2016-2021 ($ Millions)
Figure 30. Europe Tick-borne Encephalitis Vaccine Sales 2016-2021 (K Doses)
Figure 31. Europe Tick-borne Encephalitis Vaccine Revenue 2016-2021 ($ Millions)
Figure 32. Middle East & Africa Tick-borne Encephalitis Vaccine Sales 2016-2021 (K Doses)
Figure 33. Middle East & Africa Tick-borne Encephalitis Vaccine Revenue 2016-2021 ($ Millions)
Figure 34. Americas Tick-borne Encephalitis Vaccine Sales Market Share by Country in 2020
Figure 35. Americas Tick-borne Encephalitis Vaccine Revenue Market Share by Country in 2020
Figure 36. Americas Tick-borne Encephalitis Vaccine Sales Market Share by Type in 2020
Figure 37. Americas Tick-borne Encephalitis Vaccine Sales Market Share by Application in 2020
Figure 38. United States Tick-borne Encephalitis Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 39. Canada Tick-borne Encephalitis Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 40. Mexico Tick-borne Encephalitis Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 41. Brazil Tick-borne Encephalitis Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 42. APAC Tick-borne Encephalitis Vaccine Sales Market Share by Region in 2020
Figure 43. APAC Tick-borne Encephalitis Vaccine Revenue Market Share by Regions in 2020
Figure 44. APAC Tick-borne Encephalitis Vaccine Sales Market Share by Type in 2020
Figure 45. APAC Tick-borne Encephalitis Vaccine Sales Market Share by Application in 2020
Figure 46. China Tick-borne Encephalitis Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 47. Japan Tick-borne Encephalitis Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 48. Korea Tick-borne Encephalitis Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 49. Southeast Asia Tick-borne Encephalitis Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 50. India Tick-borne Encephalitis Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 51. Australia Tick-borne Encephalitis Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 52. Europe Tick-borne Encephalitis Vaccine Sales Market Share by Country in 2020
Figure 53. Europe Tick-borne Encephalitis Vaccine Revenue Market Share by Country in 2020
Figure 54. Europe Tick-borne Encephalitis Vaccine Sales Market Share by Type in 2020
Figure 55. Europe Tick-borne Encephalitis Vaccine Sales Market Share by Application in 2020
Figure 56. Germany Tick-borne Encephalitis Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 57. France Tick-borne Encephalitis Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 58. UK Tick-borne Encephalitis Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 59. Italy Tick-borne Encephalitis Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 60. Russia Tick-borne Encephalitis Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 61. Middle East & Africa Tick-borne Encephalitis Vaccine Sales Market Share by Country in 2020
Figure 62. Middle East & Africa Tick-borne Encephalitis Vaccine Revenue Market Share by Country in 2020
Figure 63. Middle East & Africa Tick-borne Encephalitis Vaccine Sales Market Share by Type in 2020
Figure 64. Middle East & Africa Tick-borne Encephalitis Vaccine Sales Market Share by Application in 2020
Figure 65. Egypt Tick-borne Encephalitis Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 66. South Africa Tick-borne Encephalitis Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 67. Israel Tick-borne Encephalitis Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 68. Turkey Tick-borne Encephalitis Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 69. GCC Country Tick-borne Encephalitis Vaccine Revenue Growth 2016-2021 ($ Millions)
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles


★調査レポート[世界のダニ媒介性脳炎ワクチン市場予測 2021年-2026年] (コード:LPI21MY9672)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のダニ媒介性脳炎ワクチン市場予測 2021年-2026年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆